McClung Barbara G's Form 4 filing
Caribou Biosciences, Inc. (CRBU) · filed Oct 21, 2021
- Accession no.
- 0001209191-21-061294
- Filed
- Oct 21, 2021
- Trade date
- Oct 20, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $24.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McClung Barbara GCIK 0001231321 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2021 | Common Stock | XIn-the-money exerciseDisposed | −9,176 | $0.00 | $0 | 80,951 | Direct | |
| Oct 20, 2021 | Common Stock | XIn-the-money exerciseDisposed | −43 | $0.00 | $0 | 89 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 22, 2021.
Referenced by the price of 2 transactions in Table I.